DaVita Q1 2026 Earnings EPS Surges Past Estimates by 226 Yet Stock Barely Moves PRG Q1 2026 Earnings Massive EPS Beat Surprises But Market Response Remains Subdued CRNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Management and Pipeline Progress FRPH Q4 2024 Earnings EPS of 009 Reported Stock Declines Slightly Astronics Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Despite Limited Revenue Disclosure ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues GRAIL Q1 2026 Earnings EPS Beats Estimates as Losses Narrow LDOS Q1 2026 Earnings EPS Beats Estimates by Nearly 6 as Stock Rises CBAN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline Crescent Biopharma Inc CBIO Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline MSGE Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain CI Q1 2026 Earnings EPS Misses Estimates as Stock Gains on Underlying Strength